Exelixis
EXEL
#1696
Rank
HK$75.37 B
Marketcap
HK$263.94
Share price
1.92%
Change (1 day)
41.13%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company